Beth Israel Deaconess Medical Center (BIDMC) Joins Precision Biologics as Collaborators on Phase 2B Pancreatic Cancer Trial
Precision Biologics is pleased to announce the addition of Beth Israel Deaconess (BIDMC)as a collaborator...
Precision Biologics is pleased to announce the addition of Beth Israel Deaconess (BIDMC)as a collaborator...
Precision Biologics is pleased to announce the addition of Dana-Farber/Harvard Cancer Center (DF/HCC) and Massachusetts...
Dr. Philip Arlen will be speaking at this years Drug Discovery Summit June 8-9th in...
FOR IMMEDIATE RELEASE….Rockville, MD, May 20, 2015 Precision Biologics is pleased to announce the completion of...
Precision Biologics is pleased to announce the addition of both Yale Cancer Center at the...
PRECISION BIOLOGICS, INC. NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 12, 2015 at 6:00...
DARMSTADT, Germany, Feb. 2, 2015 /PRNewswire/ -- EMD Millipore, the Life Science business...